"The CRISPR technology was introduced as an mRNA," Coller said. "That is the critical feature ... its cells carry relatively ...

At a margin of 40%, Palantir delivered $476 million net income (GAAP). Overall, the company now has $6.4 billion in cash and cash equivalents. More importantly for investors, Palantir raised its FY ...

RNA interference using small interfering RNAs (siRNAs) has become a mainstay of functional gene characterization and has ...

Transplant Québec is proud to announce its participation in the 17th biennial conference held by the International Society for Organ Donation Professionals (ISODP). This event will take place in Kyoto ...

Every time a doctor orders a CT scan, or a child receives a lifesaving vaccine, or your phone’s GPS corrects itself by the ...

After months of uncertainty, Aspen has confirmed that its contractual dispute regarding the mRNA vaccine has been settled, ...

Michael Burry’s sizable put options on PLTR suggest cautious skepticism, even as the stock’s memetic narrative fuels ...

In conclusion, this new saliva-based biosensor represents a big step forward in how we detect and monitor heart failure. By making screening more accessible and affordable, it could help millions of ...

The decades-long quest to harness the power of messenger RNA to enhance cancer treatment has focused primarily on its value ...

The observation that mRNA vaccines can sensitize tumors to immunotherapy has researchers eager to test how mRNA’s ability to activate the immune system could be harnessed in oncology.

Yale researchers have developed a new vaccine that does double duty against a rare and aggressive skin cancer by targeting ...

The study, published in the journal Nature, showed the jabs provided an immunity boost that helped extend survival for ...